Publications by authors named "Mi Kwon Son"

Are you Mi Kwon Son?   Register this Author

Radiosensitization of the PI3K inhibitor HS-173 through reduction of DNA damage repair in pancreatic cancer.
Oncotarget 2017 Dec 1;8(68):112893-112906. Epub 2017 Dec 1.
Department of Drug Development, College of Medicine, Inha University, Sinheung-dong, Jung-gu, Incheon 400-712, Republic of Korea.

Methylation-dependent loss of RIP3 expression in cancer represses programmed necrosis in response to chemotherapeutics.
Cell Res 2015 Jun 8;25(6):707-25. Epub 2015 May 8.
1] Department of Biochemistry, Ajou University School of Medicine, Suwon 443-380, Korea [2] Department of Biomedical Sciences, Graduate School, Ajou University, Suwon 443-380, Korea.

A novel imidazopyridine derivative, HS-106, induces apoptosis of breast cancer cells and represses angiogenesis by targeting the PI3K/mTOR pathway.
Cancer Lett 2013 Feb 17;329(1):59-67. Epub 2012 Oct 17.
Department of Biomedical Sciences, College of Medicine, Inha University, 3-ga, Sinheung-dong, Jung-gu, Incheon, Republic of Korea

Suppression of tumor proliferation and angiogenesis of hepatocellular carcinoma by HS-104, a novel phosphoinositide 3-kinase inhibitor.
Cancer Lett 2013 Jan 15;328(1):176-87. Epub 2012 Aug 15.
Department of Biomedical Sciences, College of Medicine, Inha University, 3-ga, Sinheung-dong, Jung-gu, Incheon 400-712, Republic of Korea.

Corrigendum to "Oncolytic adenovirus expressing relaxin (YDC002) enhances therapeutic efficacy of gemcitabine against pancreatic cancer" [Cancer Lett. 396 (2017) 155-166].
Cancer Lett 2017 09 22;404:93. Epub 2017 Jun 22.
Department of Biomedical Sciences, College of Medicine, Inha University, 3-ga, Sinheung-dong, Jung-gu, Incheon 400-712, Republic of Korea. Electronic address:

OF